restoring effective anti-tumor response in hodgkin lymphoma with nivolumab
Published 8 years ago • 199 plays • Length 3:47Download video MP4
Download video MP3
Similar videos
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
1:12
optimizing treatment in hodgkin lymphoma
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
1:15
the future for the treatment of hodgkin lymphoma
-
33:15
hodgkin lymphoma: how treatment may change in 2023 | what you should be asking your doctor
-
4:38
advocating for hodgkin lymphoma care: jenny's immunotherapy story
-
4:21
lymphoma: diagnosis, stages, treatment and life afterwards
-
3:56
phase i study of tinostamustine in pre-treated patients with r/r hodgkin lymphoma
-
1:37
the role of ctdna in hodgkin lymphoma
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:59
hodgkin lymphoma: prognostic markers in the era of novel treatments
-
1:38
predicting response to car-t therapy in lymphoma: challenges and strategies
-
3:07
keynote-204 in r/r classical hodgkin lymphoma
-
1:36
re-evaluating the role of radiation therapy in lymphoma & exploring combinations with immunotherapy
-
0:37
immune checkpoint inhibitors: shaping the future of lymphoma
-
2:44
data on new therapeutic strategies in hodgkin lymphoma
-
1:56
optimal therapy sequencing for hodgkin lymphoma
-
2:00
updates on treatment methods for hodgkin lymphoma
-
2:19
gemcitabine and bendamustine as a salvage regimen for recurrent/refractory hodgkin lymphoma
-
2:12
results from a phase i trial of tinostamustine in patients with r/r classical hl
-
1:54
nivolumab ibrutinib for patients with richter’s transformation